Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Apr;74(4):439–442. doi: 10.1136/jnnp.74.4.439

One year changes in disability in multiple sclerosis: neurological examination compared with patient self report

E Hoogervorst 1, M Eikelenboom 1, B Uitdehaag 1, C Polman 1
PMCID: PMC1738360  PMID: 12640058

Full Text

The Full Text of this article is available as a PDF (131.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Freeman J. A., Thompson A. J., Fitzpatrick R., Hutchinson M., Miltenburger C., Beckmann K., Dahlke F., Kappos L., Polman C., Pozzilli C. Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life. Neurology. 2001 Nov 27;57(10):1870–1875. doi: 10.1212/wnl.57.10.1870. [DOI] [PubMed] [Google Scholar]
  2. Goodkin D. E. EDSS reliability. Neurology. 1991 Feb;41(2 ):332–332. doi: 10.1212/wnl.41.2_part_1.332. [DOI] [PubMed] [Google Scholar]
  3. Hobart J., Freeman J., Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain. 2000 May;123(Pt 5):1027–1040. doi: 10.1093/brain/123.5.1027. [DOI] [PubMed] [Google Scholar]
  4. Hohol M. J., Orav E. J., Weiner H. L. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999 Oct;5(5):349–354. doi: 10.1177/135245859900500508. [DOI] [PubMed] [Google Scholar]
  5. Hoogervorst E. L., Kalkers N. F., van Winsen LML, Uitdehaag B. M., Polman C. H. Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis. Mult Scler. 2001 Oct;7(5):335–339. doi: 10.1177/135245850100700510. [DOI] [PubMed] [Google Scholar]
  6. Hoogervorst E. L., van Winsen L. M., Eikelenboom M. J., Kalkers N. F., Uitdehaag B. M., Polman C. H. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology. 2001 Apr 10;56(7):934–937. doi: 10.1212/wnl.56.7.934. [DOI] [PubMed] [Google Scholar]
  7. Jacobs L. D., Cookfair D. L., Rudick R. A., Herndon R. M., Richert J. R., Salazar A. M., Fischer J. S., Goodkin D. E., Granger C. V., Simon J. H. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol. 1996 Mar;39(3):285–294. doi: 10.1002/ana.410390304. [DOI] [PubMed] [Google Scholar]
  8. KURTZKE J. F. A new scale for evaluating disability in multiple sclerosis. Neurology. 1955 Aug;5(8):580–583. doi: 10.1212/wnl.5.8.580. [DOI] [PubMed] [Google Scholar]
  9. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
  10. Lublin F. D., Reingold S. C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 Apr;46(4):907–911. doi: 10.1212/wnl.46.4.907. [DOI] [PubMed] [Google Scholar]
  11. Noseworthy J. H. Clinical scoring methods for multiple sclerosis. Ann Neurol. 1994;36 (Suppl):S80–S85. doi: 10.1002/ana.410360718. [DOI] [PubMed] [Google Scholar]
  12. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  13. Sharrack B., Hughes R. A. Reliability of distance estimation by doctors and patients: cross sectional study. BMJ. 1997 Dec 20;315(7123):1652–1654. doi: 10.1136/bmj.315.7123.1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sharrack B., Hughes R. A. Scale development and Guy's Neurological Disability Scale. J Neurol. 1999 Mar;246(3):226–226. doi: 10.1007/s004150050340. [DOI] [PubMed] [Google Scholar]
  15. Sharrack B., Hughes R. A., Soudain S., Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain. 1999 Jan;122(Pt 1):141–159. doi: 10.1093/brain/122.1.141. [DOI] [PubMed] [Google Scholar]
  16. Sharrack B., Hughes R. A. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler. 1999 Aug;5(4):223–233. doi: 10.1177/135245859900500406. [DOI] [PubMed] [Google Scholar]
  17. Stevenson V. L., Miller D. H., Leary S. M., Rovaris M., Barkhof F., Brochet B., Dousset V., Filippi M., Hintzen R., Montalban X. One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):713–718. doi: 10.1136/jnnp.68.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Weinshenker B. G., Rice G. P., Noseworthy J. H., Carriere W., Baskerville J., Ebers G. C. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain. 1991 Apr;114(Pt 2):1057–1067. doi: 10.1093/brain/114.2.1057. [DOI] [PubMed] [Google Scholar]
  19. Whitaker J. N., McFarland H. F., Rudge P., Reingold S. C. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler. 1995 Apr;1(1):37–47. doi: 10.1177/135245859500100107. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Publisher's Correction: Abstract]
jnnpsyc_74_4_439__index.html (1.1KB, html)
jnnpsyc_74_4_439__1.html (2.7KB, html)
jnnpsyc_74_4_439__2.pdf (52.7KB, pdf)

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES